The U.S. Nuclear Regulatory Commission (NRC) opened a 30-day public comment period seeking feedback on its draft document outlining training and experience requirements for administrating radiopharmaceuticals requiring a written directive.
The federal agency published a notice in the Federal Register on May 2 asking for comment on its draft approaches. Oral comments will also be accepted during two public meetings taking place May 14 and May 23. Each will be accessible remotely; the details will be updated on the NRC’s website 10 days prior to the meetings.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) will be submitting comments, according to a news release, and is urging members to submit their own feedback by the end of the comment period on June 3.
SNMMI submitted prior comments to the NRC regarding training and experience requirements for authorized users for medical uses under Subpart E, “Unsealed Byproduct Material—Written Directive Required,” which emphasized patient and public safety in addition to quality access to care.